|
In the last fifty years, the pharmacologic therapies available to alleviate pain have changed remarkably little. With this lull in the delivery of novel analgesics, SMi is proud to present its 8th Annual Pain Therapeutics Conference. This conference will gather the key industry experts to determine how today’s challenges in pain therapeutics can be overcome, covering pressing issues such as combating neuropathic pain and assessing novel targets for pain relief. Groundbreaking developments and updates to be covered include: - HOT NEW TARGETS for effective pain relief
- SUCCESSFUL AND NOVEL approaches to neuropathic and neurological pain
- NEW AND EVOLVING ANALGESICS in development.
- THE RELEVANCE of translational pharmacology to neurological pain
- THE IMPORTANCE of animal pain models
Covering essential updates from the past 12 months, this conference will be delivered by an excellent panel of speakers including: - Dr Linda Surh, Director, CEDD Global Regulatory Affairs, GlaxoSmithKline
- Dr Tony Ho, Senior Director, Clinical Neurosciences, Merck
- Dr Joachim Scholpp, Associate Head Therapeutic Area CNS, Boehringer-Ingelheim
- Dr Aldemar Degroot, Scientist, Exploratory Development Department, Astellas
The continual and consistent success of the SMi Group’s Pain Therapeutics Conferences has established its reputation as a cornerstone conference in the field. 2008’s Pain Therapeutics Conference cannot afford to be missed to keep up to date with the most cutting-edge, revolutionary developments.
|
Events Home Page
